|
Re: SP 884+ Week Low.
|
6
|
Resverlogix Corp.
|
Oct 16, 2022 09:01AM
|
|
Re: Epigenetics and Coronavirus
|
6
|
Resverlogix Corp.
|
Mar 23, 2020 10:42AM
|
|
Re: Should I do a blog posting about Resverlogix?
|
6
|
Resverlogix Corp.
|
Apr 30, 2016 12:48PM
|
|
Re: Where's the kool aid gang?
|
6
|
Resverlogix Corp.
|
May 20, 2022 06:44PM
|
|
Amarin Patent issue and Litigation
|
6
|
Resverlogix Corp.
|
Mar 31, 2020 10:03AM
|
|
Re: Option #2
|
6
|
Resverlogix Corp.
|
Sep 11, 2020 07:04AM
|
|
Re: So how long have they been sitting on the FDA response?
|
6
|
Resverlogix Corp.
|
Sep 07, 2022 06:45PM
|
|
Re: What's the deal with Zenith?
|
6
|
Zenith Epigenetics
|
Jun 24, 2023 02:29PM
|
|
Re: Nasdaq listing -- Awesome News!!
|
6
|
Resverlogix Corp.
|
Jul 31, 2018 05:49PM
|
|
Re: COVID-19 and BRD4: a stormy and cardiotoxic bromo-romance
|
6
|
Resverlogix Corp.
|
Nov 10, 2021 12:53PM
|
|
Re: Qatar Research overview of apabetalone
|
6
|
Resverlogix Corp.
|
Apr 24, 2024 12:36PM
|
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
6
|
Resverlogix Corp.
|
Mar 26, 2022 09:10AM
|
|
Re: RESVERLOGIX ANNOUNCES VOTING RESULTS FROM THE 2022 MEETING OF SHAREHOLDERS
|
6
|
Resverlogix Corp.
|
Jun 22, 2022 12:55PM
|
|
Re: A new day for RVX
|
6
|
Resverlogix Corp.
|
May 13, 2021 10:42AM
|
|
Re: RVX's place in therapy - future prediction
|
6
|
Resverlogix Corp.
|
Mar 14, 2021 11:07AM
|
|
FDA Technology Modernization Action Plan courtesy of rndtbl on IV
|
6
|
Resverlogix Corp.
|
Nov 11, 2019 10:36AM
|
|
Epizyme market cap $750 mil USd
|
6
|
Zenith Epigenetics
|
Jun 15, 2017 01:08PM
|
|
Re: Middle Eastern $
|
6
|
Resverlogix Corp.
|
Sep 03, 2023 04:18PM
|
|
Re: Zenith share issue
|
6
|
Zenith Epigenetics
|
Nov 15, 2017 12:39PM
|
|
Re: Shareholder Value
|
6
|
Zenith Epigenetics
|
Aug 06, 2021 10:09PM
|
